Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ERP29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
APBB1IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC85B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMCES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTTG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FIBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NGLY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APRT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX8A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTP4A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on